Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 7, 2011, Pages 1315-1321

  Gheit, Tarik ^a   Cornet, Iris ^a   Clifford, Gary M ^a   Iftner, Thomas ^b   Munk, Christian ^c   Tommasino, Massimo ^a   Kjaer, Susanne K ^c,d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CELL LINEAGE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CYTOLOGY; DNA VIRUS INFECTION; EUROPE; FEMALE; GENE SEQUENCE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; VIRAL CLEARANCE;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DENMARK; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENETICS, POPULATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 79959542447     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1187     Document Type: Article

References (40)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer 2002;2:342-50.
2. Maucort-Boulch D, Plummer M, Castle PE, Demuth F, Safaeian M, Wheeler CM, et al. Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology. Int J Cancer 2010;126:684-91.
3. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
4. Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence. J Natl Cancer Inst 2010;102:1478-88.
5. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005;337:76-84. (Pubitemid 40725441)
6. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-9. (Pubitemid 41417924)
7. Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 2005;97:1066-71. (Pubitemid 41417923)
8. Chaturvedi AK, Brinkman JA, Gaffga AM, Dumestre J, Clark RA, Braly PS, et al. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J Gen Virol 2004;85:1237-41. (Pubitemid 38659787)
9. Picconi MA, Alonio LV, Sichero L, Mbayed V, Villa LL, Gronda J, et al. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 2003;69:546-52. (Pubitemid 36249869)
10. Sathish N, Abraham P, Peedicayil A, Sridharan G, Chandy G. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett 2005;229:93-9. (Pubitemid 41262544)
11. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002;185:1229-37. (Pubitemid 34439129)
12. Radhakrishna PM, Sreevidya S, Pollock BH, Jayaprakash PG, Herman B. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol Oncol 2002;87:268-73. (Pubitemid 36034646)
13. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81 (Pt 12):2959-68. (Pubitemid 32000643)
14. Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30. (Pubitemid 32910573)
15. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 2002;11:343-51. (Pubitemid 34408213)
16. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer 2009;125:2609-13.
17. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 2010;70:3159-69.
18. Seedorf K, Kr€ammer G, D€urst M, Suhai S, R€owekamp WG. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5. (Pubitemid 15234421)
19. Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006;118:1071-6. (Pubitemid 43185592)
20. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72. (Pubitemid 27078630)
21. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 2004;74:117-26. (Pubitemid 38988868)
22. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001;94:711-6. (Pubitemid 33035692)
23. Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, et al. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 2006;15:820-2.
24. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988 January 29;239:487-91. (Pubitemid 18084310)
25. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007;16:4-10. (Pubitemid 46174256)
26. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999;82:203-7. (Pubitemid 29293778)
27. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998;78:166-71. (Pubitemid 28443172)
28. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993 November;67:6413-23.
29. Hu X, Pang T, Guo Z, Mazurenko N, Kisseljov F, Pontén J, et al. HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br J Cancer 2001;84:791-5. (Pubitemid 32275652)
30. HuX,PangT,GuoZ,PontenJ,NisterM,BernardAG.Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J Pathol 2001;195:307-11.
31. Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S, et al. Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol In press. 2011.
32. Ortiz M, Torres M, Muñoz L, Fernández-García E, Canals J, Cabornero AI, et al. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006;44:1428-34.
33. Del Mistro A, Salamanca HF, Trevisan R, Bertorelle R, Parenti A, Bonoldi E, et al. Human papillomavirus typing of invasive cervical cancers in Italy. Infect Agent Cancer 2006;1:9.
34. Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005;201:1069-75. (Pubitemid 40524675)
35. Arias-Pulido H, Joste N, Wheeler CM. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1 *0602 haplotype. Genes Chromosomes Cancer 2004;40:277-84. (Pubitemid 38902538)
36. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001;93:315-8. (Pubitemid 32219819)
37. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 2002;186:696-700. (Pubitemid 34925543)
38. Chen Z, Terai M, Fu L, Herrero R, Desalle R, Burk RD. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005;79:7014-23. (Pubitemid 40677333)
39. Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, et al. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst. 2006;98:1045-52. (Pubitemid 44288152)
40. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993;67:6413-23.